U.S. Life Sciences Stock News

Oklo (NYSE:OKLO) announced plans for a privately funded advanced nuclear fuel recycling facility intended to improve fuel use and reduce waste. The company is expanding into radioisotope production through its acquisition of Atomic Alchemy, targeting new commercial applications. Oklo also reported deeper partnerships with firms including Meta Platforms and Siemens Energy, aimed at broader adoption of its clean energy solutions. For investors watching NYSE:OKLO, these moves come as the stock...

In recent weeks, Hershey has been challenged by public claims from a Reese family member that Reese’s ingredients have been cheapened, which the company disputes, while also confronting softer unit sales, higher costs and pressure on operating margins. This clash between brand heritage concerns and evidence of less profitable incremental growth raises questions about how resilient Hershey’s product portfolio and pricing power really are. Next, we’ll examine how this ingredient controversy,...

Earlier in February 2026, Birkenstock Holding plc reported higher first-quarter sales of €401.9 million and net income of €50.56 million, reaffirmed its full-year 2026 guidance, outlined plans to open about 40 new own-retail stores, and said its Board will consider a potential share repurchase program. Taken together with easing tariff pressures and a continued push into closed shoes, these moves highlight Birkenstock’s focus on controlled expansion, brand stewardship, and potentially more...

What recent performance says about Novavax (NVAX) Novavax (NVAX) has quietly posted mixed share performance recently, with a 1 day return of 1.7%, a 7 day move of 7.6%, and gains over the past month and past 3 months. For longer term holders the picture is different, with a 1 year total return of 26.3%, around 8% over 3 years, and a much weaker 5 year outcome, which may influence how you frame risk and expectations. See our latest analysis for Novavax. At a share price of $9.36, Novavax has...

Allegiant Travel (ALGT) has drawn fresh attention after unveiling Flight #925, a themed Orlando to Knoxville route created with Dollywood Parks & Resorts. The offering pairs air travel with exclusive theme park, entertainment, and lodging perks. See our latest analysis for Allegiant Travel. The latest Flight #925 announcement comes after a stretch of strong momentum in Allegiant Travel’s share price, with a 43% 90 day share price return and 27.06% 1 year total shareholder return, contrasted...

Recent performance snapshot Ciena (CIEN) has attracted fresh attention after a strong share price move over the past month, with a return of about 50%, and roughly 76% over the past 3 months. This has prompted investors to reassess the stock. See our latest analysis for Ciena. That surge comes on top of a 40.1% year to date share price return and a very large 1 year total shareholder return. Together, these point to strong recent momentum and a meaningful shift in how the market is pricing...

If you are looking at Perrigo and wondering whether the recent share price reflects its true worth, this article will walk you through what the numbers are saying about value. The stock closed at US$14.55, with returns of 0.1% over 7 days, a 1.2% decline over 30 days, 4.8% year to date, and declines of 39.1% over 1 year, 54.5% over 3 years, and 58.8% over 5 years, which can change how investors see both risk and upside potential. Recent news coverage around Perrigo has focused on its...

KB Home (KBH) is back in focus after analysts flagged that upcoming results are expected to show weaker revenue and earnings versus last year, with recent estimate changes appearing to weigh more heavily on the stock. See our latest analysis for KB Home. At a share price of US$64.36, KB Home has seen a 9.01% 1 month share price return and a 12.77% year to date share price return. The 3 year total shareholder return of 90.48% contrasts with softer recent moves as analysts focus on potentially...

Recent share performance context for TransDigm Group Recent price moves in TransDigm Group (TDG) have drawn investor attention, with the stock showing mixed returns across different periods and prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for TransDigm Group. The recent pullback, with a 1 month share price return of an 8.67% decline and a year to date share price return of a 4.59% decline from US$1,296.15, contrasts with a 1 year total shareholder...

Earlier in 2026, Trump Media & Technology Group saw its post-merger trading momentum weaken as the stock slipped to new lows amid shifting market sentiment and technical pressure. Traders have highlighted fading short interest, increasingly bearish option positioning, and mixed insider transactions as key signals shaping how investors interpret the company’s public-market debut phase. We’ll now examine how the combination of bearish trading setups and recent insider activity may influence...

If you are wondering whether Okta's share price today reflects its true worth, you are not alone. This article will walk through how the current market view compares with several common valuation checks. Okta's share price closed at US$69.51, with returns of 20.3% decline over 7 days, 23.4% decline over 30 days, 16.9% decline year to date, 23.5% decline over 1 year, 3.0% decline over 3 years, and 74.2% decline over 5 years. These moves may have shifted how investors think about its risk and...

Wendy's (WEN) is back in focus after management paired cautious 2026 guidance, including flat global systemwide sales, with plans to close 5% to 6% of U.S. stores and rising pressure from activist Trian Partners. See our latest analysis for Wendy's. At a share price of US$7.77, Wendy's has seen a 3.9% one day share price decline and a 7.8% 90 day share price return decline, while the 1 year total shareholder return is down 48.3%. This suggests that recent activist headlines and cautious...

NewAmsterdam Pharma Company N.V. reported past full-year 2025 results on February 18, showing sales of US$22.5 million and a net loss of US$203.82 million, while also filing an omnibus shelf registration for up to 5,719,966 common shares. Despite lower revenue and continued losses, analysts highlighted management’s confidence in obicetrapib’s late-stage trials and regulatory path, underscoring its central role in the company’s future. We’ll now examine how confidence in obicetrapib’s...

In February 2026, Bank of America Corporation completed and announced multiple senior unsecured bond offerings across maturities from 2027 to 2046 totaling several hundred million US dollars, while also unveiling a new Art Consulting service for wealth clients and deepening its data partnership with London Stock Exchange Group. Together with a US$25.00 billion commitment to private-credit deals, these moves highlight Bank of America’s push to broaden fee and interest income sources across...

If you are wondering whether Kirby's current share price truly reflects its underlying value, you are not alone. That is exactly what this article will unpack. With the stock at US$128.46 after a 2.8% gain over the last 7 days, a flat 0.2% move over 30 days, and returns of 14.8% year to date, 27.3% over 1 year, 76.4% over 3 years and 100.0% over 5 years, many investors are asking what is already priced in. Recent attention on Kirby has largely centered on its role in the U.S. marine...

Supplier OMI has announced a new active cathode material that supports full battery charging in about three minutes. Harley-Davidson, listed as NYSE:HOG, is identified as a potential beneficiary as an existing participant in OMI's supplier base. Discussions have started between OMI and Harley-Davidson on how this technology could be scaled for future electric motorcycle platforms. Harley-Davidson's share price stands at $19.37, with returns of a 5.1% decline over the past week, a 4.6%...

If you are wondering whether ASGN is starting to look like value after a rough stretch, this article will walk through what the current share price might be telling you. The stock closed at US$40.94, with returns of a 1.2% decline over 7 days, 19.8% decline over 30 days, 12.3% decline year to date, 40.3% decline over 1 year, 54.0% decline over 3 years and 57.2% decline over 5 years. These moves may be changing how investors think about its risk and potential. Recent news coverage around ASGN...

MPLX LP recently raised its quarterly distribution by 12.5%, lifting its forward yield to 7.71% and reinforcing its fee-based midstream model supported by long-term contracts with Marathon Petroleum extending into the 2030s. This step, underpinned by strong contracted cash flows and disciplined capital allocation, signals management’s confidence in sustaining meaningful distribution growth for years. We’ll now explore how this sizable distribution increase and its backing by long-term...

Victory Capital Holdings (VCTR) has drawn investor attention after recent share price moves, with the stock last closing at $74.33. That puts recent monthly and past 3 months returns into sharper focus. See our latest analysis for Victory Capital Holdings. The recent 1-month share price return of 9.36% and 3-month share price return of 17.82% suggest building momentum. A 1-year total shareholder return of 18.98% and a very large 5-year total shareholder return indicate that longer term...

Recent commentary on Chewy (CHWY) has focused on two issues: slowing projected sales growth and the company’s broad definition of subscription revenue, even as it reports ongoing revenue growth and sustained profitability. See our latest analysis for Chewy. Chewy’s share price, now at $24.71, has seen a 1-day share price return decline of 6.58% and a 30-day share price return decline of 22.03%. Its 1-year total shareholder return decline of 28.29% underlines fading momentum as investors...

Monster Beverage (MNST) is back in focus after several major banks upgraded their views, pointing to management execution, strong free cash flow and a solid balance sheet ahead of a closely watched quarterly earnings update. See our latest analysis for Monster Beverage. The recent wave of bank upgrades and attention around the upcoming Q4 2025 earnings call comes after Monster Beverage’s share price climbed to US$84.69, with a 90 day share price return of 13.19% and a 1 year total shareholder...

Main Street Capital (NYSE:MAIN) has expanded its revolving credit facility with the addition of a new lender. This increases available commitments and gives the company more financing capacity for future activity. Main Street Capital, trading at $56.78, has seen mixed recent performance, with a 4.5% decline over the past week and an 11.4% decline over the past month. Over longer periods, returns have been more positive, including a 70.5% gain over three years and 127.1% over five years,...

Camtek stock moves and recent performance snapshot Camtek (NasdaqGM:CAMT) has recently attracted investor attention after a mix of short term pullback and longer term strength, with the share price up over the past month and past 3 months despite a weaker week. See our latest analysis for Camtek. At a share price of $153.11, Camtek has seen momentum cool slightly in the past week, but its 30 day share price return of 6.6% sits alongside a very strong 1 year total shareholder return of 95.3%...

Event overview and recent performance context Zevra Therapeutics (ZVRA) has attracted attention recently as investors reassess its rare disease pipeline alongside its current trading level of US$8.70. Recent returns range from a 1.1% decline over the past day to a 16.8% gain over the past year. See our latest analysis for Zevra Therapeutics. For Zevra, a 4.3% year to date share price return and 16.8% one year total shareholder return suggest momentum has been building, even as shorter term...